Wearables detect illness
New 2026 coverage shows smartwatches are being pushed to detect early signs of illness by tracking vital‑sign patterns — a shift from simple step counts to proactive health alerts. (Recent reporting highlights breakthrough sensor use and clinical‑style warning patterns.) ( )
Apple’s watchOS 11 “Vitals” feature shipped alongside the Apple Watch Series 11 in September 2025 and Apple’s product pages explicitly promoted new hypertension‑related notifications for Series 11. (apple.com) Users and early testers have reported Vitals‑style alerts flagging potential illness up to three days before symptoms, a pattern noted in coverage and user reports on MacRumors and Heise. (macrumors.com) Google’s Fitbit Labs rolled out an “Unusual Trend Detection” experiment and a Fitbit Hypertension study that sought as many as 10,000 U.S. participants and provided ambulatory blood‑pressure monitors to a subset for clinical validation. (wareable.com) Oura’s recently announced Symptom Radar was developed with partners including UCSF and TemPredict data and the company says the feature can detect physiological changes roughly 2 to 2.75 days before users log illness tags during its validation. (ouraring.com) Academic trials underpin many claims: Stanford’s large‑scale monitoring system detected about 80% of confirmed COVID‑19 cases at or before symptom onset in its Phase 2 dataset, and Scripps/DETECT reported an AUC around 0.80 when combining resting heart rate, sleep, and activity to distinguish COVID‑positive from negative symptomatic cases. (med.stanford.edu) Regulatory and commercial momentum is visible—FDA lists show more than 200 sensor‑based digital health clearances between 2014–2025, Biofourmis has won FDA breakthrough/clearance milestones for its analytics platform, and new 510(k)‑cleared multiparameter wearables such as the UbiqVue 2A are targeting continuous home monitoring. (medtechspectrum.com)
